Mortality benefit of angiotensin-converting enzyme inhibitors after cardiac events in patients with end-stage renal disease

Mortality benefit of angiotensin-converting enzyme inhibitors after cardiac events in patients with end-stage renal disease

Hypothesis/Introduction The risks and benefits of angiotensin-converting enzyme (ACE) inhibitors in patients with end-stage renal disease (ESRD) after cardiac events are unknown. We sought to determine the independent effect of ACE inhibitors (ACE-I) on long-term mortality in ESRD patients after car...

Full description

Bibliographic Details
Main Authors: Peter A McCullough, Keisha R Sandberg, Jerry Yee, Michael P Hudson
Format: Article
Language:English
Published: Hindawi - SAGE Publishing 2002-09-01
Series:Journal of the Renin-Angiotensin-Aldosterone System
Online Access:https://doi.org/10.3317/jraas.2002.040

Internet

https://doi.org/10.3317/jraas.2002.040

Similar Items